-Reuters
Uncategorized
Cuomo Says Most COVID-Era Capacity Restrictions To End Across Tri-State Area On May 19
-Reuters
Related Posts
Regenxbio’s Earnings Outlook
Regenxbio (NASDAQ:RGNX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement.
Analysts estimate that Regenxbio will report an earnings per share (EPS) of $-1.46.
Morgan Stanley Maintains Equal-Weight on Jack In The Box, Raises Price Target to $85
Morgan Stanley analyst Brian Harbour maintains Jack In The Box (NASDAQ:JACK) with a Equal-Weight and raises the price target from $79 to $85.
Raymond James Maintains Outperform on DexCom, Lowers Price Target to $538
Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Outperform and lowers the price target from $618 to $538.